Biotech drug startup NuvOx Pharma was awarded the 2017 TechConnect Defense Innovation Award based on the potential positive impact the submitted technology will have for the warfighter and national security.
top of page
Search
Recent Posts
See AllTucson, AZ, September 6th, 2024 – NuvOx Pharma LLC, a wholly owned subsidiary of NuvOx Therapeutics Inc. (together, “NuvOx”) announced...
Tucson, AZ, June 30th, 2024 – NuvOx Pharma LLC (“NuvOx”) announced that it has received authorization from Health Canada for its EXTEND:...
Tucson, AZ, January 2, 2024 - NuvOx Pharma has been issued US Patent No. 11,857,627, entitled “Fractionated Radiotherapy and...
bottom of page
Comments